Prevail Therapeutics Inc.
Biotechnology company · New York, United States
Prevail Therapeutics Inc. is a biotechnology company headquartered in New York, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $57 million sold in a notice filed in 2018.
Prevail Therapeutics at a glance
What does Prevail Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $57 million sold (2018).
Frequently asked questions about Prevail Therapeutics
Where is Prevail Therapeutics headquartered?
Prevail Therapeutics Inc. is headquartered in New York, United States.
What does Prevail Therapeutics do?
Prevail Therapeutics Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
When was Prevail Therapeutics founded?
The earliest incorporation on record for Prevail Therapeutics Inc. is in 2017, according to public company registers.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences